Glenmark Pharma’s Q2 profit plunges 57 pc to Rs 264 crore; revenue drops 30 pc
Glenmark Pharmaceuticals on Thursday reported a 56.7 per cent year-on-year (YoY) decline in consolidated net profit to Rs 264 crore for the quarter ended September 2026 (Q2 FY27),…
Attributed summary
Glenmark Pharmaceuticals on Thursday reported a 56.7 per cent year-on-year (YoY) decline in consolidated net profit to Rs 264 crore for the quarter ended September 2026 (Q2 FY27), compared with Rs 610 crore in the corres...
Read the original report — Tripuratimes
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.
